Runwood Homes, a company in the media more and more recently for repeatedly failing to provide safe provisions for its residents is in trouble with health inspectors once again.

It was uncovered during an inspection earlier this month in Glenabbey Manor in Newtownabbey, Belfast, Northern Ireland that there were potentially harmful issues with medication. It also emerged that management were aware of issues, but action to address the problems have not been taken.

The Regulation and Quality Improvement Authority (RQIA), a health watchdog in Northern Ireland, has issued a ‘failure to comply’ notice to the management of the home.

The notice was issued just seven months after they were banned from admitting new residents following concerns about current residents’ safety.

A report from the RQIA stated the home were not keeping medication reports properly.

The RQIA could not be certain whether medication being given to one resident was still being prescribed, and the inspector was unable to tell whether correct dosages were being given to residents.

The RQIA report said: “There were duplicate supplies of some medicines on the medicine trolley, which could result in the resident being administered some medicines twice. The outcome of the inspection gave rise to concerns regarding the competency and capability of care team managers.”

A spokesman for Runwood Homes said: “We have been working with the RQIA to ensure that our drugs management and medical record regimes are more robust and that every member of staff is fully aware and in compliance with all regulations at all times.

“There has been a turnover of staff at Glenabbey Manor over the past six month which has been challenging for medical management in terms of training and the imbedding of protocols.

However, we are now on top of this and can confirm that no resident has suffered any ill-effect and all staff are now fully compliant with all training.”